대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지

항암단 투여로 호전된 진행성 또는 전이성 담낭암 연속환자증례

Case Series of Advanced or Metastatic Gallbladder Cancer Patients Treated with Hang-Am-Dan

  • 김경순 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터) ;
  • 정태영 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터)
  • Kim, Kyung-Soon (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Jung, Tae-Young (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University)
  • 발행 : 2010.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : To investigate the therapeutic effects of Hang-Am-Dan(HAD) on gallbladder cancer patients. Method : We prescribed HAD three times a day(3,000-6,000 mg/day) during a treatment period of 8 and 34 months respectively. Computed tomography(CT) was taken to evaluate the therapeutic efficacy. Results : Two patients diagnosed with gallbladder cancer were recommended to go through chemotherapy. However, they refused the standard regimen due to their old age and the fear of side effects, and chose to go with Oriental medicine treatments instead. The patients were treated for 8 and 34 months respectively. Each patient showed stable disease(SD) state during the treatment period. Conclusion : According to these cases, it could be concluded that HAD may offer potential benefits in treating gallbladder cancer patients.

키워드

참고문헌

  1. Goetze T, Paolucci V. Does laparoscopy worsen the prognosis for incidental gallbladder cancer? Surg Endosc. 2006;20(2):286-93. https://doi.org/10.1007/s00464-005-0121-x
  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics. 2006;56(2): 106-30.
  3. Lim SB, Kim KH, Kim SW, Yoon YB, Park YH. A clinical study of prognostic factors in gallbladder cancer. J Korean Surg Soc. 1998; 55(1):120-31.
  4. Grobmyer SR, Lieverman MD, Daly JM. Gallbladder cancer in the twentieth century: single institution's experience. World J Surg. 2004;28(1):47-9. https://doi.org/10.1007/s00268-003-7131-4
  5. 박재갑 외. 종양학. 서울: (주)일조각; 2003, p. 417.
  6. Fauci 외. 해리슨 내과학 17판. 서울: 도서출판 IP; 2010, p. 708.
  7. 서영광, 김은희, 김달래, 고병희, 전성하, 어완규 외. 폐전이된 담낭암 환자를 사상의학적 관리를 통해 제반 증상과 삶의 질을 개선시킨 1례. 사상체질의학회지. 2007;19(2):187-94.
  8. 송창훈, 이슬희, 김정철, 오성워, 정종진, 황진우 외. 원위부 담도암 환자 증례 보고. 대한한방내과학회지. 2006;27(3):777-82.
  9. 서상훈, 유화승, 이용연, 송기철, 최병렬, 조종효 외. 췌장전이를 동반한 담도암환자 1례에 대한 보고. 대한한방내과학회지. 2002;23(4):735-40.
  10. Mekeel KL. Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188-93. https://doi.org/10.1007/s11605-007-0115-1
  11. Chan CP, Chang HC, Chen YL, Yang LH, Chen ST, Kuo SJ, et al. A 10-year experience of unsuspected gallbladder cancer after laparoscopic cholecystectomy. Int Surg. 2003;88:175-9.
  12. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-76. https://doi.org/10.1016/S1470-2045(03)01021-0
  13. Muratore A, Polastri R, Bouzari H, Vergara V, Capussotti L. Radical surgery for gallbladder cancer: a worthwhile operation? Eur J Surg Oncol. 2000;26:160-3. https://doi.org/10.1053/ejso.1999.0762
  14. Sean P. Cleary, Laura A. Dawson, Jennifer J. Knox, Steven Gallinger. Cancer of the Gallbladder and Extrahepatic Bile Ducts. Current Problems in Surgery. 2007;44(7):396-482. https://doi.org/10.1067/j.cpsurg.2007.04.006
  15. Takada Tadahiro, Amano Hodaka, Yasuda Hideki, Nimura Yuji, Masushiro Takasi, Hiroyukii et al. Is Postoperative Adjuvant Chemotherapy Useful for Gallbladder Carcinoma? : A Phase III Multicenter Prospective Randomized Controlled Trial in Patients with Resected Pancreaticobiliary Carcinoma. Cancer. 2002;95(8):1685-95. https://doi.org/10.1002/cncr.10831
  16. 이승원, 김형철, 주종우, 정준철, 정귀애. 담낭암 환자에서 gemcitabine을 기본으로 한 보조 항암화학요법의 경험. 대한외과학회지. 2008;75(4): 255-61.
  17. 이용연, 서상훈, 유화승, 최우진, 조정효, 이연월 등. 항암단을 투여한 대장암 환자 83례에 대한임상보고. 대한한방종양학회지. 2000;6(1):165-80.
  18. 최병렬, 이용연, 유화승, 서상훈, 최우진, 조정효 등. 항암단을 투여한 유방암 환자 60례에 대한임상보고. 대한한방내과학회지. 2001;22(4):669-74.
  19. 유승후, 유화승, 조종관, 이연월. 항암단을 투여한 재발성 편평상피폐암 환자에 대한 7년간의 추적조사. 대한한방내과학회지. 2007;28(2):385-90.
  20. 이남헌, 윤담희, 유화승, 조정효, 손창규, 이연월 등. 항암단으로 치료한 암환자 100례의 혈청 VFGF, bEGF 및 platelet 수치변화. 대한한방내과학회지. 2005;26(4):753-60.